Updated:
January 13, 2021 12:03 IST
A failure to investigate the conduct of the recent Covaxin phase-3 trial can affect the course of other studies under way
Share Article
AAA
A failure to investigate the conduct of the recent Covaxin phase-3 trial can affect the course of other studies under way
More than a decade since the human clinical trial of the human papilloma virus (HPV) vaccine it was controversial and carried out without proper consent on nearly 23,500 girls in the 10-14 age group in Vadodara, Gujarat and Khammam district of Andhra Pradesh and eight years after the Supreme Court of India slammed the government for slipping into “deep slumber” in addressing the “menace” of illegal clinical trials carried out in India by multinational countries, nothing much seems to have changed.